Opinion
Case No. 3:11-cv-01610-JCS 3:11-cv-00840-JCS 3:11-cv-01609-JCS
10-13-2011
TAKEDA PHARMACEUTICAL CO., LTD., TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS LLC, AND TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs, v. IMPAX LABORATORIES, INC., Defendant.
[PROPOSED] ORDER ON STIPULATION OF DISMISSAL PURSUANT TO FED. R. CIV. P. 41(a)(1) and (c)
Having considered the parties' Stipulation of Dismissal of Count XI (False Marking) of Defendant Impax's Counterclaims ("Count XI"), IT IS ORDERED that Count XI is hereby dismissed without prejudice, with each party to bear its own costs.
SO ORDERED:
THE HONORABLE JOSEPH C. SPERO
UNITED STATES MAGISTRATE JUDGE